FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Peter Iversen

Research Profile

Disorders

Prostatic Neoplasms

Chemicals & Drugs

Procedures

Physiology

Disease Progression

Concepts & Ideas

Co-author Network

Publications

TOP 3
Martin Andreas Røder; Ea Rusch; Frederik Birkebæk Thomsen; Kasper Drimer Berg; Klaus Brasso; Lisa Gruschy; Peter Iversen
Patients undergoing radical prostatectomy have a better survival than the background population.
Frederik Birkebæk Thomsen; Helle Hvarness; Peter Iversen; Martin Andreas Røder; Klaus Brasso
Active surveillance can reduce overtreatment in patients with low-risk prostate cancer.
Martin Andreas Røder; Peter Iversen
[Radical prostatectomy in patients with advanced prostate cancer].

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Peter Iversen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Martin Andreas Røder; Ea Rusch; Frederik Birkebæk Thomsen; Kasper Drimer Berg; Klaus Brasso; Lisa Gruschy; Peter Iversen
Patients undergoing radical prostatectomy have a better survival than the background population.
Danish medical journal 2013;60(4):A4612.
2013: Frederik Birkebæk Thomsen; Helle Hvarness; Peter Iversen; Martin Andreas Røder; Klaus Brasso
Active surveillance can reduce overtreatment in patients with low-risk prostate cancer.
Danish medical journal 2013;60(2):A4575.
2012: Martin Andreas Røder; Peter Iversen
[Radical prostatectomy in patients with advanced prostate cancer].
Ugeskrift for laeger 2012;174(50):3160-1.
2012: Joel Aanerud; Mahmoud Ashkanian; Per Borghammer; M Mallar Chakravarty; Peter Iversen; Peter Johannsen; Kristjana Y Jónsdottir; Arne Moller; Anders Rodell; Manouchehr S Vafaee; Kim Vang; Albert Gjedde
Brain energy metabolism and blood flow differences in healthy aging.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2012;32(7):1177-87.
2011: Peter Iversen; Susanne Keiding; Kim Mouridsen; Peter Ott; Hendrik Vilstrup
Transjugular intrahepatic portosystemic shunt does not alter cerebral blood flow.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2011;9(11):1001-3.
2011: Charlotte Elberling Almasi; Klaus Brasso; Peter Iversen; Helle Pappot; Gunilla Høyer-Hansen; Keld Danø; Ib J Christensen
Prognostic and predictive value of intact and cleaved forms of the urokinase plasminogen activator receptor in metastatic prostate cancer.
The Prostate 2011;71(8):899-907.
2011: Renata Leke; Lasse K Bak; Peter Iversen; Michael Sørensen; Susanne Keiding; Hendrik Vilstrup; Peter Ott; Luis V Portela; Arne Schousboe; Helle S Waagepetersen
Synthesis of neurotransmitter GABA via the neuronal tricarboxylic acid cycle is elevated in rats with liver cirrhosis consistent with a high GABAergic tone in chronic hepatic encephalopathy.
Journal of neurochemistry 2011;117(5):824-32.
2011: M Andreas Røder; Kasper D Berg; Klaus Brasso; Lisa Gruschy; Peter Iversen
First danish single-institution experience with radical prostatectomy: biochemical outcome in 1200 consecutive patients.
Prostate cancer 2011;2011():236357.
2010: Peter Iversen; David G McLeod; Thomas Morris; William A See; Manfred P Wirth; Jon Armstrong
Antiandrogen monotherapy in patients with localized or locally advanced prostate cancer: final results from the bicalutamide Early Prostate Cancer programme at a median follow-up of 9.7 years.
BJU international 2010;105(8):1074-81.
2009: Lasse K Bak; Peter Iversen; Mette Sørensen; Susanne Keiding; Hendrik Vilstrup; Peter Ott; Helle S Waagepetersen; Arne Schousboe
Metabolic fate of isoleucine in a rat model of hepatic encephalopathy and in cultured neural cells exposed to ammonia.
Metabolic brain disease 2009;24(1):135-45.
2009: Soeren Junge Nielsen; Peter Iversen; Jens F Rehfeld; Helle Lone Jensen; Jens Peter Goetze
C-type natriuretic peptide in prostate cancer.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2009;117(1):60-7.
2007: Maja L Johansen; Lasse K Bak; Arne Schousboe; Peter Iversen; Mette Sørensen; Susanne Keiding; Hendrik Vilstrup; Albert Gjedde; Peter Ott; Helle S Waagepetersen
The metabolic role of isoleucine in detoxification of ammonia in cultured mouse neurons and astrocytes.
Neurochemistry international 2007;50(7-8):1042-51.
2006: Chris J Tyrrell; Peter Iversen; Teuvo Tammela; John Anderson; Thomas Björk; Amir V Kaisary; Tom Morris
Tolerability, efficacy and pharmacokinetics of bicalutamide 300 mg, 450 mg or 600 mg as monotherapy for patients with locally advanced or metastatic prostate cancer, compared with castration.
BJU international 2006;98(3):563-72.
2006: Peter Iversen; Jan-Erik Johansson; Pär Lodding; Timo Kylmälä; Per Lundmo; Peter Klarskov; Teuvo L J Tammela; Ilker Tasdemir; Tom Morris; Jon Armstrong
Bicalutamide 150 mg in addition to standard care for patients with early non-metastatic prostate cancer: updated results from the Scandinavian Prostate Cancer Period Group-6 Study after a median follow-up period of 7.1 years.
Scandinavian journal of urology and nephrology 2006;40(6):441-52.
2005: Chris J Tyrrell; Heather Payne; William A See; David G McLeod; Manfred P Wirth; Peter Iversen; Jon Armstrong; Clive Morris
Bicalutamide ('Casodex') 150 mg as adjuvant to radiotherapy in patients with localised or locally advanced prostate cancer: results from the randomised Early Prostate Cancer Programme.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2005;76(1):4-10.
2005: Johan Stranne; Jonas Hugosson; Peter Iversen; Tom Morris; Pär Lodding
Inguinal hernia in stage M0 prostate cancer: a comparison of incidence in men treated with and without radical retropubic prostatectomy--an analysis of 1105 patients.
Urology 2005;65(5):847-51.
2004: Peter Iversen; Jan-Erik Johansson; Pär Lodding; Olavi Lukkarinen; Per Lundmo; Peter Klarskov; Teuvo L J Tammela; Ilker Tasdemir; Tom Morris; Kevin Carroll
Bicalutamide (150 mg) versus placebo as immediate therapy alone or as adjuvant to therapy with curative intent for early nonmetastatic prostate cancer: 5.3-year median followup from the Scandinavian Prostate Cancer Group Study Number 6.
The Journal of urology 2004;172(5 Pt 1):1871-6.
2004: Manfred P Wirth; William A See; David G McLeod; Peter Iversen; Tom Morris; Kevin Carroll
Bicalutamide 150 mg in addition to standard care in patients with localized or locally advanced prostate cancer: results from the second analysis of the early prostate cancer program at median followup of 5.4 years.
The Journal of urology 2004;172(5 Pt 1):1865-70.
2004: Peter R Carroll; June M Chan; Anthony V D'amico; Edward P Gelmann; Peter Iversen; Laurence Klotz; Joel B Nelson; Peter S Nelson; William G Nelson; William K Oh; Neal Rosen; Mark A Rubin; Howard Sandler; William R Sellers; Matthew R Smith; Jianfeng Xu; Mary Carole McMann; Philip W Kantoff
Fourth International Conference on Innovations and Challenges in Prostate Cancer: Prevention, Detection and Treatment.
The Journal of urology 2004;172(5 Pt 2):S3-5.
2004: Peter Iversen; Manfred P Wirth; William A See; David G McLeod; Ira W Klimberg; Donald Gleason; Gerald Chodak; James E Montie; Chris J Tyrrell; D M A Wallace; Karl P J Delaere; Per Lundmo; Teuvo L J Tammela; Jan-Erik Johansson; Tom Morris; Kevin Carroll
Is the efficacy of hormonal therapy affected by lymph node status? data from the bicalutamide (Casodex) Early Prostate Cancer program.
Urology 2004;63(5):928-33.
2003: Peter R Carroll; David A Benaron; George Blackledge; Fergus V Coakley; Anthony V D'amico; Celestia S Higano; Peter Iversen; Michael W Kattan; David M Nanus; Joel B Nelson; William K Oh; Mack Roach; William R Sellers; Matthew R Smith; Mary Carole McMann; Philip W Kantoff
Third international conference on innovations and challenges in prostate cancer: prevention, detection and treatment.
The Journal of urology 2003;170(6 Pt 2):S3-5.
2003: William A See; Peter Iversen; M Wirth; D McLeod; L Garside; Tom Morris
Immediate treatment with bicalutamide 150mg as adjuvant therapy significantly reduces the risk of PSA progression in early prostate cancer.
European urology 2003;44(5):512-7; discussion 517-8.
2003: Chris J Tyrrell; G M Blake; Peter Iversen; Amir V Kaisary; I Melezinek
The non-steroidal antiandrogen, bicalutamide ('Casodex'), may preserve bone mineral density as compared with castration: results of a preliminary study.
World journal of urology 2003;21(1):37-42.
2002: Peter Iversen; Teuvo L J Tammela; Sigmund Vaage; Olavi Lukkarinen; Pär Lodding; T Bull-Njaa; Jouko Viitanen; P Hoisaeter; Per Lundmo; F Rasmussen; Jan-Erik Johansson; B-E Persson; Kevin Carroll
A randomised comparison of bicalutamide ('Casodex') 150 mg versus placebo as immediate therapy either alone or as adjuvant to standard care for early non-metastatic prostate cancer. First report from the Scandinavian Prostatic Cancer Group Study No. 6.
European urology 2002;42(3):204-11.
2002: Peter Iversen
Antiandrogen monotherapy: indications and results.
Urology 2002;60(3 Suppl 1):64-71.
2002: William A See; Manfred P Wirth; David G McLeod; Peter Iversen; Ira W Klimberg; Donald Gleason; Gerald Chodak; James E Montie; Chris J Tyrrell; D M A Wallace; Karl P J Delaere; Sigmund Vaage; Teuvo L J Tammela; Olavi Lukkarinen; Bo-Eric Persson; Kevin Carroll; Geert J C M Kolvenbag
Bicalutamide as immediate therapy either alone or as adjuvant to standard care of patients with localized or locally advanced prostate cancer: first analysis of the early prostate cancer program.
The Journal of urology 2002;168(2):429-35.
2002: Per Olov Hedlund; Martti Ala-Opas; Einar Brekkan; Jan-Erik Damber; Lena Damber; Inger Hagerman; Svein Haukaas; Peter Henriksson; Peter Iversen; Ake Pousette; Finn Rasmussen; Jaakko Salo; Sigmund Vaage; Eberhard Varenhorst
Parenteral estrogen versus combined androgen deprivation in the treatment of metastatic prostatic cancer -- Scandinavian Prostatic Cancer Group (SPCG) Study No. 5.
Scandinavian journal of urology and nephrology 2002;36(6):405-13.
2001: Peter Iversen; I Melezinek; A Schmidt
Nonsteroidal antiandrogens: a therapeutic option for patients with advanced prostate cancer who wish to retain sexual interest and function.
BJU international 2001;87(1):47-56.
2000: Peter Iversen; Chris J Tyrrell; Amir V Kaisary; JB Anderson; Hein Van Poppel; Teuvo L J Tammela; M Chamberlain; Kevin Carroll; I Melezinek
Bicalutamide monotherapy compared with castration in patients with nonmetastatic locally advanced prostate cancer: 6.3 years of followup.
The Journal of urology 2000;164(5):1579-82.
1998: Peter Iversen; Chris J Tyrrell; Amir V Kaisary; JB Anderson; L Baert; Teuvo Tammela; M Chamberlain; Kevin Carroll; K Gotting-Smith; George Blackledge
Casodex (bicalutamide) 150-mg monotherapy compared with castration in patients with previously untreated nonmetastatic prostate cancer: results from two multicenter randomized trials at a median follow-up of 4 years.
Urology 1998;51(3):389-96.
1998: Chris J Tyrrell; Amir V Kaisary; Peter Iversen; JB Anderson; L Baert; Teuvo Tammela; M Chamberlain; A Webster; George Blackledge
A randomised comparison of 'Casodex' (bicalutamide) 150 mg monotherapy versus castration in the treatment of metastatic and locally advanced prostate cancer.
European urology 1998;33(5):447-56.
1997: Peter Iversen; F Rasmussen; C Asmussen; I J Christensen; J Eickhoff; Peter Klarskov; E Larsen; P Mogensen; S Mommsen; P Rosenkilde
Estramustine phosphate versus placebo as second line treatment after orchiectomy in patients with metastatic prostate cancer: DAPROCA study 9002. Danish Prostatic Cancer Group.
The Journal of urology 1997;157(3):929-34.
1996: Peter Iversen; K Tveter; E Varenhorst
Randomised study of Casodex 50 MG monotherapy vs orchidectomy in the treatment of metastatic prostate cancer. The Scandinavian Casodex Cooperative Group.
Scandinavian journal of urology and nephrology 1996;30(2):93-8.
1993: H Ovesen; Peter Iversen; R Beier-Holgersen; Tage Hald; F Rasmussen; Kenneth Steven
Extraperitoneal pelvioscopy in staging of bladder carcinoma and detection of pelvic lymph node metastasis.
Scandinavian journal of urology and nephrology 1993;27(2):211-4.
1990: S Møller; Peter Iversen; M B Franzmann
Flutamide-induced liver failure.
Journal of hepatology 1990;10(3):346-9.
1989: Peter Iversen; M Bak; N Juul; F Laursen; H von der Maase; L Nielsen; F Rasmussen; S Torp-Pedersen; HH Holm
Ultrasonically guided 125iodine seed implantation with external radiation in management of localized prostatic carcinoma.
Urology 1989;34(4):181-6.